News

In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.
VX-880 stem cell therapy led to 92% reduction in insulin use, with 10 out of 12 patients eliminating injections entirely in a ...
Small, 3D-printed devices, designed to be implanted directly under the skin, could allow people with type 1 diabetes to ...
A dozen volunteers with severe type 1 diabetes showed clear improvements in their condition 12 months after receiving a ...
Teplizumab offers a completely different approach. Instead of simply replacing insulin, it targets the immune attack that causes type 1 diabetes.